An official website of the United States government
Home
Name
DVM
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for DVM
Name
Alternate Names
Methyl G
Methyl-GAG
Methylglyoxal Bisguanylhydrazone
mitoguazone dihydrochloride
Abbreviations
MeG
MeGAG
MGA
MGBG
MGGH
Category
Chemotherapy
Subcategory
Antineoplastic hydrazone
NSC Number
32946
Primary Site
AIDS
Opportunistic infection
Histology
None
Remarks
A hydrazone antitumor agent. At present, mitoguazone should be available on an as-needed basis in institutions routinely treating cancer patients, including AIDS-related non-Hodgkin's lymphoma.
Coding
This drug should be coded
Name
Alternate Names
Cis-Platin
Cis-Platinum II#
Cisplatino (Spanish)
Cisplatinum
Cisplatyl
Neoplatin
Peyrone's chloride
Platinex
Platinol
Platinol-AQ
Platinol-AQ VHA Plus
Platinum
Abbreviations
CACP
CDDP
Cis-DDP
CPD
CPDC
CPDD
CPPD
DDP
Category
Chemotherapy
Subcategory
Alkylating agent
Platinum analog
NSC Number
119875
Primary Site
Histology
None
Remarks
An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.
Coding
This drug should be coded
Name
Alternate Names
Compound 112531
Eldesine
Eldisine
Lilly 99094
LY-099094
Vincaleukoblastine
Vindesine sulfate
Abbreviations
DAVA
DVA
Category
Chemotherapy
Subcategory
Plant alkyloid
NSC Number
245467
Primary Site
None
Histology
None
Remarks
Vindesine has activity in a wide variety of malignancies including colorectal, lung, breast, and esophageal carcinomas; it also has activity in lymphomas and leukemias, glioma, and melanoma. Neurotoxicity (dose-limiting and cumulative) and cross-resistance with vincristine have limited the usefulness of this agent. Although vindesine in combination with cisplatin is one of the most active regimens for non-small cell lung cancer.
Coding
This drug should be coded
